| 10-Q | 2018-06-30 | Filed 2018-08-17 |
| 10-Q | 2018-03-31 | Filed 2018-07-06 |
| 10-K | 2017-12-31 | Filed 2018-04-05 |
| 10-Q | 2017-09-30 | Filed 2017-11-20 |
| 10-Q | 2017-06-30 | Filed 2017-08-15 |
| 10-Q | 2017-03-31 | Filed 2017-05-22 |
| 10-K | 2016-12-31 | Filed 2017-04-12 |
| 10-Q | 2016-09-30 | Filed 2016-11-14 |
| 10-Q | 2016-06-30 | Filed 2016-08-16 |
| 10-Q | 2016-03-31 | Filed 2016-05-17 |
| 10-K | 2015-12-31 | Filed 2016-03-30 |
| 10-Q | 2015-09-30 | Filed 2015-11-18 |
| 10-Q | 2015-06-30 | Filed 2015-08-17 |
| 10-Q | 2015-03-31 | Filed 2015-05-15 |
| 10-K | 2014-12-31 | Filed 2015-03-31 |
| 10-Q | 2014-09-30 | Filed 2014-11-19 |
| 10-Q | 2014-06-30 | Filed 2014-08-19 |
| 10-Q | 2014-03-31 | Filed 2014-05-09 |
| 10-K | 2013-12-31 | Filed 2014-02-07 |
| 10-Q | 2013-09-30 | Filed 2013-10-08 |
| 8-K | 2018-08-20 | |
| 8-K | 2018-07-31 | |
| 8-K | 2018-03-15 | |
| 8-K | 2018-03-07 | |
| 8-K | 2018-01-25 | |
| 8-K | 2018-01-22 | |
| 8-K | 2018-01-02 |
| Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rebel Group (REBL) | 0% | 0.0 | -1,380% | 703 | 4,933 | 140 | 0 | -9,708 | -9,660 | -395 | |
| Generex Biotechnology (GNBT) | 21% | 0.0 | -49% | 52,240 | 43,297 | 1,764 | 374 | -25,717 | -18,297 | -540 | |
| Poverty Dignified (POVD) | 0.0 | -4,053% | 49 | 3,080 | 0 | 0 | -2,000 | -1,786 | -41 | ||
| Zhong Ya (WLUC) | 0.0 | 0 | 63 | 0 | 0 | -562 | -562 | -0 | |||
| Weyland Tech (WEYL) | 18% | 2.2 | -24% | 11,699 | 2,218 | 24,630 | 4,372 | -2,779 | -2,702 | -5,821 | |
| Longbau (LNGB) | 4% | -1.0 | 2% | 10,660 | 10,136 | 4,882 | 210 | 165 | 222 | -233 | |
| Scandium International Mining (SCY) | 0.1 | -171% | 957 | 303 | 0 | 0 | -1,636 | -1,634 | -219 | ||
| Aprea Therapeutics (APRE) | 8.4 | -11% | 57,336 | 9,943 | 0 | 0 | -6,249 | -6,249 | -52,334 | ||
| IntelliSense Solutions (INLL) | 0.0 | -7,286% | 2 | 273 | 0 | 0 | -178 | -164 | -2 | ||
| Metropolitan Life Insurance (MLIC) | 0% | -1.8 | 1% | 437,745,000 | 403,121,000 | 37,348,000 | 0 | 4,559,000 | 4,960,000 | -8,986,000 | |
| Zeta Acquisition I (ZETAI) | 0.2 | -649% | 4 | 324 | 0 | 0 | -29 | -18 | -4 | ||
| Ando Holdings (ANDO) | 1.1 | -74% | 73 | 160 | 0 | 0 | -54 | -54 | -61 | ||
| Po Yuen Cultural (POYE) | 0.0 | -1,973% | 1 | 68 | 0 | 0 | -20 | -20 | -0 | ||
| Advanced Biomedical Technologies (ABMT) | 0.0 | -321% | 218 | 6,589 | 0 | 0 | -701 | -701 | -11 | ||
| Kyto Technology & Life Science (KBPH) | 0% | 0.8 | -12% | 2,578 | 66 | 15 | 0 | -315 | -315 | -238 | |
| Federal Home Loan Bank of Topeka (FHLBT) | 29.6 | 0% | 57,131,130 | 54,472,808 | 0 | 0 | 132,964 | 1,095,234 | 32,380,961 | ||
| CNL Healthcare Properties II (CHPII) | 67% | -4.4 | 68,889,100% | 8,277 | 5,549 | -689 | 1,137 | -4,981 | |||
| Original Source Music (OSMU) | 0.0 | 743,400% | 35 | 0 | 0 | -7 | -7 | -0 | |||
| Graham Alternative Investment Fund I (GAIF) | -0.0 | 0% | 29,076 | 1,126 | 0 | 0 | 0 | 5 | -0 | ||
| JiaLiJia Group (RZZN) | 0.0 | -1,721% | 4 | 139 | 0 | 0 | -69 | -69 | -0 |
| Balance Sheet ($'000) | 2013-09-30 | 2013-12-31 | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 |
| Cash | 0 | 0 | 0 | 4 | 6 | 5 | 1 | 1 | 20 | 6 | 10 | 6 | 1 | 3 | 2 | 1 | 4 | 1 | 2 |
| Accounts Receivable | |||||||||||||||||||
| Inventory | 7 | 5 | 22 | 134 | |||||||||||||||
| PP&E | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27 | 24 | ||||||
| Assets | 0 | 0 | 0 | 15 | 14 | 8 | 10 | 12 | 46 | 24 | 41 | 58 | 49 | 51 | 50 | 38 | 48 | 32 | 163 |
| Accounts Payable | |||||||||||||||||||
| Long-Term Debt | 0 | ||||||||||||||||||
| Liabilities | 1 | 2 | 3 | 20 | 24 | 32 | 51 | 71 | 65 | 54 | 52 | 39 | 31 | 40 | 54 | 42 | 70 | 73 | 101 |
| Stockholders' Equity | -1 | -2 | -3 | -4 | -9 | -25 | -41 | -59 | -19 | -30 | -11 | 19 | 17 | 11 | -3 | -4 | -22 | -40 | 61 |
| Income Statement ($'000) | 2013-09-30 | 2013-12-31 | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 |
| Revenue | 0 | 0 | 0 | 9 | 16 | 21 | 9 | 18 | 10 | 28 | 40 | 37 | 45 | 0 | 23 | 19 | 5 | 33 | |
| Cost of Revenue | 8 | 14 | 16 | 8 | 14 | 1 | 17 | 9 | 22 | 25 | -2 | 10 | 7 | 2 | 30 | ||||
| Gross Profit | 1 | 1 | 5 | 3 | 6 | 9 | 11 | 31 | 15 | 21 | 3 | 13 | 13 | 4 | -29 | 3 | |||
| R&D | |||||||||||||||||||
| SG&A | 1 | 2 | 4 | 7 | 1 | 6 | 16 | 31 | 5 | -2 | 16 | 17 | 13 | 9 | 10 | 6 | 9 | 11 | 37 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Net Income | -1 | -2 | -5 | -2 | -5 | -19 | -16 | -23 | -4 | -14 | 5 | -45 | -502 | -11 | -15 | 487 | -21 | -41 | -12,567 |
| Cash Flow ($'000) | 2013-09-30 | 2013-12-31 | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 |
| Cash Operating | -1 | 0 | 0 | -13 | -16 | -17 | -23 | -5 | -18 | -16 | 1 | -33 | -2 | -3 | -1 | 8 | -32 | -1 | -4 |
| Cash Investing | 0 | 0 | -1 | 0 | 1 | 0 | 0 | -6 | |||||||||||
| Cash Financing | -1 | 1 | 0 | 18 | 23 | 23 | 20 | 5 | 36 | 2 | 3 | 65 | -5 | 5 | 0 | -9 | 35 | 4 | 4 |